scispace - formally typeset
Open AccessJournal ArticleDOI

The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: A systematic review

TLDR
CVD risk among SLE patients compared to the general population is at least doubled, and young women have alarmingly high relative risks, given the rarity of CVD in the comparison general population.
About
This article is published in Seminars in Arthritis and Rheumatism.The article was published on 2013-08-01 and is currently open access. It has received 286 citations till now. The article focuses on the topics: Relative risk & Population.

read more

Citations
More filters
Journal ArticleDOI

Systemic lupus erythematosus.

TL;DR: The 10-year mortality has improved and toxic adverse effects of older medications such as cyclophosphamide and glucocorticoids have been partially offset by newer drugs such as mycophenolate mofetil and glucose-sparing regimes.
Journal ArticleDOI

Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association.

TL;DR: The intent of this American Heart Association (AHA) scientific statement is to summarize the current understanding of dilated cardiomyopathies, with special emphasis on recent developments in diagnostic approaches and therapies for specific cardiologyopathies.
References
More filters
Journal ArticleDOI

Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men

TL;DR: The reduction associated with the use of aspirin in the risk of a first myocardial infarction appears to be directly related to the level of C-reactive protein, raising the possibility that antiinflammatory agents may have clinical benefits in preventing cardiovascular disease.
Journal ArticleDOI

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPRISMA: Explanation and Elaboration

TL;DR: The updating of the QUOROM Statement is described, to ensure clear presentation of what was planned, done, and found in a systematic review, and the name of the reporting guidance was changed to PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses).
Related Papers (5)